REGULATIONS Archives

Alzheimer’s Phase 3 Drugs Face High Hopes but Low Success Odds

04/10/2024by EOS Intelligence

Many biopharmaceutical companies, such as AriBio, Annovis Bio, Athira Pharma, Cassava Sciences, and Alzheon, specializing in treating neurodegenerative diseases, are developing drugs for Alzheimer’s disease (AD) that are currently in...

Asia Pushes Wholesale CBDCs to Cut Cross-Border Costs and Dollar Dependence

22/08/2024by EOS Intelligence

The emergence of Central Bank Digital Currencies (CBDCs) has become a central focus in the global financial space, as it offers the potential for revolutionary shifts in how the world...

Charting the RegTech Journey: Navigating Consolidation

09/07/2024by EOS Intelligence

RegTech, short for regulatory technology and often categorized as a subset of fintech, emerged in 2015. The RegTech industry was fragmented, with numerous small players targeting specific niches within the...

IRA: Are Patients Winning at the Cost of the US Pharma Sectoral Growth?

20/06/2024by EOS Intelligence

The market reaction to the US Inflation Reduction Act of 2022 is mostly mixed. It is expected to change the pharma industry dynamics in terms of the competitive positioning and...

An Era of Innovation: Novel Drugs Redefining Multiple Sclerosis Treatment Paradigm

30/05/2024by EOS Intelligence

Since the approval of the first drug, interferon beta 1b (IFNβ-1b), in 1993, the treatment landscape of multiple sclerosis (MS) has significantly changed. Currently, there exist more than 20 disease-modifying...

Anti-Obesity Drugs – Pharma Companies Race to Grab a Bite of the Pie

16/04/2024by EOS Intelligence

For many years, bariatric surgery has been the go-to option for people struggling with obesity and obesity-induced conditions. However, for the last couple of years, another easier option has become...

P2P Lending Needs More than Just an Appetite for Investment by EOS Intelligence

P2P Lending Needs More than Just an Appetite for Investment to Sustain Its Growth

02/04/2024by EOS Intelligence

Peer-to-peer (P2P) lending has emerged as a global financial phenomenon. It has revolutionized the way individuals access loans. The innovation of P2P lending has experienced varying degrees of success and...

Europe AI Regulation Deal – Beginning of a New Technological Era?

18/03/2024by EOS Intelligence

The proliferation of artificial intelligence (AI) applications in recent years has highlighted the importance of regulatory frameworks to ensure AI’s responsible use. Recognizing this, the EU has become the first...

Who We Are

Connect With Us

Work With EOS